VijiNair United StatesUniversity of Michigan

Institution

Day 1 - Sunday April 14, 2024

Time Session
9 a.m.
10:30 a.m.
SK1001
HeatherAscani Chairperson United StatesUniversity of Michigan
KatherineTuttle Chairperson United StatesUniversity of Washington School of Medicine, Division of Nephrology
MatthiasKretzler Chairperson United StatesUniversity of Michigan
  • Looking for Data on Glomerular Diseases: How to Find the Treasures You Are Looking for With a Click of a Mouse
    VijiNair Speaker United StatesUniversity of Michigan
  • Open Science in an Open Community: Resources of the Kidney Precision Medicine Project for CKD and AKI
    MatthiasKretzler Speaker United StatesUniversity of Michigan
  • The Future is Now: How to Mine Cells and Neighborhoods of the Kidney in Health and Disease
    JulioSaez-Rodriguez Speaker julio.saez@uni-heidelberg.deGermanyHeidelberg University
  • Panel Discussion
Hall C1
10:30 a.m.
11 a.m.
SPOT-O3
JonathanBarratt Spotlight Speaker United KingdomUniversity of Leicester, Leicester, UK
Spotlight Stage 1 (exhibition hall)
11 a.m.
12 p.m.
PL2
AgnesFogo Chairperson United States
GuillermoRosa Diez Chairperson guillermo.rosadiez@hospitalitaliano.org.arArgentinaHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of Nephrology
  • My Story
    VictoriaGray Speaker vwright_03@yahoo.comUnited States
  • CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture
    Obiageli EuniceNnodu Speaker oennodu@gmail.comNigeriaUniversity of Abuja
Hall A
3 p.m.
4 p.m.
SK02
RafaelMaldonado Chairperson ramaldonado@gmail.comArgentina
ReikoInagi Chairperson JapanThe University of Tokyo Graduate School of Medicine
  • Understanding Glomerular Damage: From Spatial Transcriptomics to Chip Technology
    LauraPerin Speaker LPerin@chla.usc.eduUnited States
  • Spatial Metabolomics of Kidney Disease
    TonRabelink Speaker a.j.rabelink@lumc.nlNetherlandsLUMC
  • Constructing an Epigenetic Network for Diabetic Nephropathy
    Sam El-Osta Speaker sam.el-osta@baker.edu.auAustraliaBaker Heart and Diabetes Institute
  • Q and A
Hall E

Day 2 - Monday April 15, 2024

Time Session
9 a.m.
10:30 a.m.
SK03
PaulaCoccia Chairperson paula.coccia@hospitalitaliano.org.arArgentinaHospital Italianod de Buenos Aires
Shyam BihariBansal Chairperson IndiaDepartment of Nephrology, Medanta-The Medicity, Gurgaon, India
  • Genomics of Rare Genetic Diseases: Experiences From India
    VinodScaria Speaker vinods@igib.inIndiaVishwanath Cancer Care Foundation & Indian Institute of Technology Kanpur
  • On the Way to Translate GWAS into Kidney Disease Mechanisms
    KrzysztofKiryluk Speaker United StatesColumbia University
  • X-linked Kidney Disorders in Women
    MichelleRheault Speaker rheau002@umn.eduUnited StatesUniversity of Minnesota
  • Prenatal/Preimplantation Genetic Diagnosis and Genetic Counseling for Genetic Kidney Disorders
    NineKnoers Speaker v.v.a.m.knoers@umcg.nlNetherlandsDepartment of Genetics, University Medical Centre Groningen, Groningen, The Netherlands
  • Q and A
Hall E
11 a.m.
12 p.m.
PL3
Jose VicenteSanchez Polo Chairperson visanpolo@gmail.comGuatemalaRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH)
MegJardine Chairperson AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia
  • Generative AI Revolution in Medicine
    MichalRosen-Zvi Speaker ROSEN@il.ibm.comIsraelhttps://research.ibm.com/
  • Acceptance Speech by Awardee (Schrier Award), with Tasnuva Sarah Kashem (UK) and Farnaz Nobi (Bangladesh)
    Mohammad Shakib Uz ZamanArefin Speaker shakib04@yahoo.comBangladesh
Hall A

Day 3 - Tuesday April 16, 2024

Time Session
9 a.m.
10 a.m.
LF1002
DebasishBanerjee Chairperson United KingdomSt George's University Hospital NHS Foundation Tr
MegJardine Chairperson AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia
  • Setting the Scene
    MegJardine Speaker AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia
  • DM and CKD: Which Treatment Should I Use for Different Populations?
    KatherineTuttle Speaker United StatesUniversity of Washington School of Medicine, Division of Nephrology
  • How to Design Studies on Answering Unanswered Questions
    VladoPerkovic Speaker AustraliaUniversity of New South Wales, Sydney, Australia
  • The Effect of SGLT2 Inhibitors in Patients with Chronic Kidney Disease, With or Without Type 2 Diabetes
    DavidWheeler Speaker United KingdomUniversity College London
  • Q and A
Hall C4

Pre-Congress - Saturday April 13, 2024

Time Session
4:30 p.m.
6 p.m.
OCPL1
  • ISN President's Address
    MasaomiNangaku Speaker Japan
  • Tribute to Stewart Cameron
  • Welcome by WHO Director of Non-Communicable Diseases Dr Bente Mikkelsen
  • Welcome by Dr. Marina Papaginovic, SAN President; Dr. Guillermo Rosa Diez, WCN Local Organising Group Chair; and Dr. Jorge Rico, SLANH President and WCN Local Organizing Group co-Chair
    GuillermoRosa Diez Speaker guillermo.rosadiez@hospitalitaliano.org.arArgentinaHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of Nephrology
    JorgeRico Speaker jorgericof@yahoo.comColombia
    MariaPapaginovic Leiva Speaker drapapaginovicleiva@gmail.comArgentina
  • Welcome by Minister of Health for Buenos Aries Dr Fern
  • Welcome by SPWG Chair Alessia Fornoni
    AlessiaFornoni Speaker United StatesUniversity of Miami
  • The Origin of the Universe
    DanielDe Florian Speaker deflo@unsam.edu.arArgentinaUniversidad Nacional de San Martin
  • Acceptance Speech: Hamburger Award
    AdeeraLevin Speaker CanadaUniversity of British Columbia and Providence Health Care
Hall A